MVision AI
About MVision AI
MVision AI is a pioneering healthcare AI company dedicated to transforming cancer care through advanced artificial intelligence solutions, primarily focusing on radiation therapy. For physicians, MVision AI offers a suite of cloud-based software designed to enhance the efficiency, consistency, and quality of radiotherapy treatment planning. Their flagship products include the Guideline-Based Segmentation (GBS™) suite, which features Contour+ for AI-powered auto-contouring, Verify for assessing contour accuracy, and Guide as a training environment to improve practitioner skills. These tools significantly reduce the manual workload involved in delineating organs-at-risk (OARs) and target volumes, with reported time savings of up to 95% in contouring processes.
Furthermore, MVision AI provides Dose+, an AI-powered solution for patient-specific dose prediction and personalized radiotherapy treatment planning. Dose+ leverages machine learning to generate tailored 3D dose estimates that align with clinical best practices, supporting plan optimization for cases such as prostate and pelvic lymph node radiotherapy. The company’s solutions are designed for seamless integration with existing DICOM-compliant treatment planning systems, empowering oncology professionals to deliver high-quality treatment plans faster and more reliably. By automating repetitive tasks and standardizing workflows, MVision AI aims to reduce treatment waiting times from weeks to days, ultimately improving access to advanced cancer care globally.
Focus Areas
Business Intelligence
| Key Investors | J12 Ventures, Voima Ventures, Icebreaker.VC, Nuard Ventures, Business Finland, Asko Schrey, Otto Söderlund |
| Partnerships | Medron Medical Systems (Canada), Meditest (France), Royal Philips (working on agreement) |
| Technology | Cloud-based (with local server option), deep learning models, Workspace+ platform (unifies contouring, synthetic imaging, dose prediction, contour propagation), DICOM-compliant integration, HIPAA and GDPR compliant |
| FDA Clearances | 3 cleared products (estimated) |
What Physicians Need to Know
MVision AI's solutions are designed to empower physicians by significantly reducing the time spent on manual contouring and treatment planning, allowing more focus on patient-specific needs and complex cases. The Guideline-Based Segmentation (GBSu2122) suite, with its training and verification tools, helps maintain high-quality, consistent, and guideline-compliant contours, fostering clinical confidence. The transparency of AI-generated outputs, which allows for review and modification, ensures clinicians remain in control. Furthermore, the seamless integration with existing DICOM-compliant treatment planning systems minimizes disruption to current workflows, while adherence to HIPAA and GDPR standards ensures patient data privacy and security. These tools address staff shortages and help reduce patient waiting times by increasing overall efficiency and quality in radiotherapy.
MVision AI's solutions are designed for seamless integration with any DICOM-compliant treatment planning system (TPS). They operate as either cloud-based web applications or local installations, offering flexibility in deployment. The system ensures data protection and patient privacy through HIPAA and GDPR compliance, with secure, encrypted data transfer.
What the Web Says
MVision AI is a company specializing in AI-powered solutions for radiotherapy treatment planning, primarily focusing on auto-contouring software. Their products, such as Contour+, Guide, and Verify, aim to automate repetitive tasks, streamline workflows, and improve consistency and accuracy in radiation therapy. The company's solutions have received positive feedback from clinicians for significantly reducing contouring time and enhancing treatment planning.
Overall: PositiveStrengths
- Significant reduction in contouring time (up to 95% reported).
- High accuracy and quality of AI-generated contours, often requiring minor or no adjustments.
- Improved consistency and standardization in radiotherapy planning across different clinics and teams.
- Enhanced clinical workflow and efficiency.
- Supports both adult and pediatric CT scans, with strong performance in pediatric cases.
- Integrates contouring with QA and training, offering an educational environment for practitioners.
Limitations
- Higher cost structure compared to some alternatives.
- Complex feature set may require substantial training.
- Newer company with a smaller user community.
- Still building an international clinical validation database for MRI.
- Some general AI tools for medical imaging are still in development and may have a high margin of error, though this is not specifically attributed to MVision AI.
- Limited information available on employer reviews on platforms like Glassdoor and Capterra, with some reviews for similarly named but different companies appearing.
Based on reviews from: Google Search, Reddit, Wellbeing Magazine, G2, Capterra, Health Data Management, alphaXRT, Slashdot, X-ray Interpreter
Last updated: 2026-07-18
Videos
News, demos, and interviews about MVision AI.
Videos load interactively. If none appear, search YouTube for MVision AI →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded MVision AI.
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]